<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_stents" title="Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents" shortTitle="stents" author="Kateřina Škrlová, Kateřina Malachová, Alexandra Muñoz-Bonilla, Dagmar Měřinská, Zuzana Rybková, Marta Fernández-García, Daniela Plachá" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/2079-4991/9/11/1548/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
3.	LS	3.
Biofilms	NNPS	Biofilms
</s>
</head>
<p>
<s type="decl">
As	IN	as
mentioned	VBN	mention
above	RB	above
,	,	,
the	DT	the
most	RBS	most
common	JJ	common
problems	NNS	problem
of	IN	of
stents	NNS	stent
are	VBP	be
due	JJ	due
to	IN	to
their	PRP$	their
clogging	NN	clogging
due	JJ	due
to	IN	to
the	DT	the
formation	NN	formation
of	IN	of
biofilm	NN	biofilm
and	CC	and
adhesion	NN	adhesion
of	IN	of
biological	JJ	biological
substances	NNS	substance
that	WDT	that
pass	VBP	pass
through	IN	through
the	DT	the
stent	NN	stent
.	.	.
</s>
<s type="decl">
Biofilm	NNP	Biofilm
represents	VBZ	represent
the	DT	the
most	RBS	most
widespread	JJ	widespread
way	NN	way
of	IN	of
microbial	JJ	microbial
growth	NN	growth
in	IN	in
nature	NN	nature
and	CC	and
is	VBZ	be
critical	JJ	critical
for	IN	for
the	DT	the
development	NN	development
of	IN	of
clinical	JJ	clinical
infections	NNS	infection
.	.	.
</s>
<s type="decl">
It	PRP	it
is	VBZ	be
produced	VBN	produce
by	IN	by
bacteria	NNS	bacteria
and	CC	and
host	NN	host
products	NNS	product
that	WDT	that
tend	VBP	tend
to	TO	to
adhere	VB	adhere
to	IN	to
different	JJ	different
surfaces	NNS	surface
.	.	.
</s>
<s type="decl">
They	PRP	they
create	VBP	create
huge	JJ	huge
colonies	NNS	colony
known	VBN	know
as	IN	as
biofilms	NNS	biofilm
.	.	.
</s>
<s type="decl">
Existence	NN	existence
in	IN	in
biofilms	NNS	biofilm
is	VBZ	be
for	IN	for
them	PRP	they
more	RBR	more
advantageous	JJ	advantageous
because	IN	because
biofilm	NN	biofilm
provides	VBZ	provide
protection	NN	protection
for	IN	for
their	PRP$	their
cells	NNS	cell
,	,	,
maintains	VBZ	maintain
a	DT	a
homeostasis	NN	homeostasis
,	,	,
and	CC	and
creates	VBZ	create
a	DT	a
barrier	NN	barrier
that	WDT	that
isolates	VBZ	isolate
bacteria	NNS	bacteria
from	IN	from
the	DT	the
surroundings	NNS	surroundings
.	.	.
</s>
<s type="decl">
There	EX	there
is	VBZ	be
extensive	JJ	extensive
communication	NN	communication
between	IN	between
bacteria	NNS	bacteria
and	CC	and
the	DT	the
effective	JJ	effective
horizontal	JJ	horizontal
transfer	NN	transfer
of	IN	of
resistance	NN	resistance
and	CC	and
virulence	NN	virulence
genes	NNS	gene
that	WDT	that
make	VBP	make
bacteria	NNS	bacteria
very	RB	very
resistant	JJ	resistant
.	.	.
</s>
<s type="decl">
Thus	RB	thus
,	,	,
bacteria	NNS	bacteria
cells	NNS	cell
in	IN	in
biofilm	NN	biofilm
are	VBP	be
more	RBR	more
resistant	JJ	resistant
to	IN	to
toxic	JJ	toxic
substances	NNS	substance
,	,	,
UV	NN	UV
radiation	NN	radiation
,	,	,
mechanical	JJ	mechanical
damage	NN	damage
,	,	,
bacteriophages	NNS	bacteriophage
,	,	,
or	CC	or
predators	NNS	predator
.	.	.
</s>
<s type="decl">
They	PRP	they
are	VBP	be
also	RB	also
more	RBR	more
resistant	JJ	resistant
to	IN	to
the	DT	the
immune	JJ	immune
system	NN	system
and	CC	and
antibiotics	NNS	antibiotics
in	IN	in
a	DT	a
human	JJ	human
or	CC	or
animal	NN	animal
body	NN	body
.	.	.
</s>
<s type="decl">
The	DT	the
surface	NN	surface
of	IN	of
the	DT	the
material	NN	material
is	VBZ	be
very	RB	very
quickly	RB	quickly
occupied	VBN	occupy
by	IN	by
bacteria	NNS	bacteria
because	IN	because
the	DT	the
host	NN	host
products	NNS	product
create	VBP	create
a	DT	a
biofilm	NN	biofilm
on	IN	on
the	DT	the
material	NN	material
that	WDT	that
helps	VBZ	help
to	TO	to
bind	VB	bind
the	DT	the
bacteria	NNS	bacteria
.	.	.
</s>
<s type="decl">
This	DT	this
process	NN	process
takes	VBZ	take
place	NN	place
in	IN	in
five	CD	5
stages	NNS	stage
,	,	,
as	IN	as
can	MD	can
be	VB	be
seen	VBN	see
in	IN	in
</s>
<figure>
<s type="frag">
Figure	NNP	Figure
3	CD	3
</s>
</figure>
<s type="frag">
.	.	.
</s>
</p>
<p>
<s type="decl">
Biofilms	NNS	biofilm
affect	VBP	affect
many	JJ	many
medical	JJ	medical
applications	NNS	application
and	CC	and
are	VBP	be
a	DT	a
serious	JJ	serious
medical	JJ	medical
problem	NN	problem
at	IN	at
the	DT	the
present	JJ	present
time	NN	time
.	.	.
</s>
<s type="decl">
They	PRP	they
are	VBP	be
found	VBN	find
,	,	,
for	IN	for
example	NN	example
,	,	,
in	IN	in
catheters	NNS	catheter
,	,	,
stents	NNS	stent
,	,	,
contact	NN	contact
lenses	NNS	lense
,	,	,
and	CC	and
many	JJ	many
other	JJ	other
implants	NNS	implant
.	.	.
</s>
<s type="decl">
Biomaterials	NNS	biomaterial
at	IN	at
risk	NN	risk
of	IN	of
attaching	VBG	attach
bacteria	NNS	bacteria
together	RB	together
with	IN	with
corresponding	VBG	correspond
body	NN	body
fluids	NNS	fluid
and	CC	and
major	JJ	major
components	NNS	component
of	IN	of
the	DT	the
host	NN	host
products	NNS	product
for	IN	for
bacterial	JJ	bacterial
growth	NN	growth
are	VBP	be
classified	VBN	classify
in	IN	in
Table	NNP	Table
1	CD	1
.	.	.
</s>
<s type="decl">
The	DT	the
biofilm	NN	biofilm
’s	POS	's
high	JJ	high
resistance	NN	resistance
to	IN	to
antibacterial	JJ	antibacterial
agents	NNS	agent
results	VBZ	result
in	IN	in
a	DT	a
great	JJ	great
risk	NN	risk
of	IN	of
infection	NN	infection
and	CC	and
therefore	RB	therefore
creates	VBZ	create
a	DT	a
very	RB	very
hazardous	JJ	hazardous
situation	NN	situation
for	IN	for
patient	JJ	patient
health	NN	health
.	.	.
</s>
<s type="decl">
Microbial	JJ	Microbial
cells	NNS	cell
that	WDT	that
live	VBP	live
in	IN	in
biofilms	NNS	biofilm
have	VBP	have
greater	JJR	great
resistance	NN	resistance
to	IN	to
antimicrobial	JJ	antimicrobial
substances	NNS	substance
than	IN	than
cells	NNS	cell
that	WDT	that
live	VBP	live
alone	RB	alone
in	IN	in
planktonic	JJ	planktonic
form	NN	form
.	.	.
</s>
<s type="decl">
Due	JJ	due
to	IN	to
this	DT	this
resistance	NN	resistance
,	,	,
the	DT	the
treatment	NN	treatment
of	IN	of
biofilm	NN	biofilm
infections	NNS	infection
is	VBZ	be
very	RB	very
difficult	JJ	difficult
.	.	.
</s>
<s type="sub">
Infected	VBN	infect
implants	NNS	implant
must	MD	must
be	VB	be
removed	VBN	remove
from	IN	from
the	DT	the
patient	NN	patient
’s	POS	's
body	NN	body
.	.	.
</s>
<s type="decl">
This	DT	this
procedure	NN	procedure
is	VBZ	be
usually	RB	usually
expensive	JJ	expensive
and	CC	and
dangerous	JJ	dangerous
for	IN	for
patients	NNS	patient
because	IN	because
surgical	JJ	surgical
procedures	NNS	procedure
can	MD	can
cause	VB	cause
other	JJ	other
complications	NNS	complication
.	.	.
</s>
<s type="decl">
Millions	NNS	million
of	IN	of
implants	NNS	implant
and	CC	and
catheters	NNS	catheter
are	VBP	be
used	VBN	use
for	IN	for
treatment	NN	treatment
every	DT	every
year	NN	year
.	.	.
</s>
<s type="decl">
Table	NNP	Table
2	CD	2
shows	VBZ	show
examples	NNS	example
of	IN	of
implants	NNS	implant
prone	JJ	prone
to	IN	to
the	DT	the
infections	NNS	infection
of	IN	of
biofilms	NNS	biofilm
.	.	.
</s>
</p>
<p>
<s type="decl">
For	IN	for
this	DT	this
reason	NN	reason
,	,	,
new	JJ	new
materials	NNS	material
are	VBP	be
being	VBG	be
developed	VBN	develop
to	TO	to
reduce	VB	reduce
the	DT	the
risk	NN	risk
of	IN	of
biofilm	NN	biofilm
formation	NN	formation
and	CC	and
infection	NN	infection
.	.	.
</s>
<s type="decl">
These	DT	this
materials	NNS	material
are	VBP	be
based	VBN	base
on	IN	on
polymer	NN	polymer
composites	NNS	composite
or	CC	or
polymers	NNS	polymer
with	IN	with
surfaces	NNS	surface
modified	VBN	modify
with	IN	with
an	DT	a
antimicrobial	JJ	antimicrobial
agent	NN	agent
.	.	.
</s>
<s type="sub">
In	IN	in
addition	NN	addition
,	,	,
other	JJ	other
options	NNS	option
based	VBN	base
on	IN	on
physical	JJ	physical
surface	NN	surface
properties	NNS	property
such	JJ	such
as	IN	as
surface	NN	surface
roughening	NN	roughening
,	,	,
or	CC	or
vice	NN	vice
versa	RB	versa
smooth	JJ	smooth
surface	NN	surface
,	,	,
super	JJ	super
hydrophobic	JJ	hydrophobic
,	,	,
etc.	JJ	etc.
should	MD	should
be	VB	be
considered	VBN	consider
.	.	.
</s>
</p>
</text>